title: Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group.
authors.affiliation: Bioanalytical Science and Toxicokinetics (BST), PTS-DMPK, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA, 19406, USA, christopher.2.evans@gsk.com.
authors.forename: Christopher
authors.initials: C
authors.lastname: Evans
authors.forename: Mark
authors.initials: M
authors.lastname: Arnold
authors.forename: Peter
authors.initials: P
authors.lastname: Bryan
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Duggan
authors.forename: Christopher A
authors.initials: CA
authors.lastname: James
authors.forename: Wenkui
authors.initials: W
authors.lastname: Li
authors.forename: Steve
authors.initials: S
authors.lastname: Lowes
authors.forename: Luca
authors.initials: L
authors.lastname: Matassa
authors.forename: Timothy
authors.initials: T
authors.lastname: Olah
authors.forename: Philip
authors.initials: P
authors.lastname: Timmerman
authors.forename: Xiaomin
authors.initials: X
authors.lastname: Wang
authors.forename: Enaksha
authors.initials: E
authors.lastname: Wickremsinhe
authors.forename: John
authors.initials: J
authors.lastname: Williams
authors.forename: Eric
authors.initials: E
authors.lastname: Woolf
authors.forename: Patricia
authors.initials: P
authors.lastname: Zane
mesh_terms: D000818:Animals; D001800:Blood Specimen Collection / Q000379:methods*; D059788:Dried Blood Spot Testing / Q000379:methods*; D004345:Drug Industry; D006801:Humans; D010599:Pharmacokinetics